![Henri Lichenstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henri Lichenstein
Fundador en Shanghai Drug Farm Biological Technology Co., Ltd. .
Cargos activos de Henri Lichenstein
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Shanghai Drug Farm Biological Technology Co., Ltd.
![]() Shanghai Drug Farm Biological Technology Co., Ltd. Information Technology ServicesTechnology Services Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development. | Director/Miembro de la Junta | 21/10/2015 | - |
Director Ejecutivo | 21/10/2015 | - | |
Fundador | 21/10/2015 | - |
Historial de carrera de Henri Lichenstein
Antiguos cargos conocidos de Henri Lichenstein.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
TOPOTARGET A/S | Corporate Officer/Principal | 27/05/2010 | - |
AI Therapeutics, Inc.
![]() AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Director Ejecutivo | 01/01/2013 | 01/05/2021 |
Fundador | 01/01/2013 | - | |
Presidente | 01/01/2013 | - | |
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
Estados Unidos | 3 |
Dinamarca | 2 |
China | 2 |
Operativa
Corporate Officer/Principal | 2 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorial
Health Technology | 4 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Topotarget A/S
![]() Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
AI Therapeutics, Inc.
![]() AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Health Technology |
Shanghai Drug Farm Biological Technology Co., Ltd.
![]() Shanghai Drug Farm Biological Technology Co., Ltd. Information Technology ServicesTechnology Services Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development. | Technology Services |
- Bolsa de valores
- Insiders
- Henri Lichenstein
- Experiencia